Reby Advisors »

GlaxoSmithKline shares owned by Reby Advisors

Quarter-by-quarter ownership of GlaxoSmithKline shares owned by Reby Advisors from 13F filings

Historical chart of Reby Advisors investment in GlaxoSmithKline

Tip: Access up to 7 years of quarterly data

All positions including GlaxoSmithKline held by Reby Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GlaxoSmithKline by Reby Advisors

Quarter filed Position value Share count Share price at filing
2020-12-31 $62k 1.7k 36.56

More positions owned by Reby Advisors

Schwab U.s. Large-cap Growth Etf Etf (SCHG)
Schwab U.s. Large-cap Value Etf Etf (SCHV)
Schwab U.s. Mid-cap Etf Etf (SCHM)
Schwab Us Aggregate Bond Etf Etf (SCHZ)
Spdr Msci Acwi Ex-us Etf Etf (CWI)
Invesco Emerging Markets Sovereign Debt Etf Etf (PCY)
Schwab U.s. Small-cap Etf Etf (SCHA)
Schwab Intermediate-term U.s. Treasury Etf Etf (SCHR)
Schwab International Equity Etf Etf (SCHF)
Ishares Russell 1000 Value Etf Etf (IWD)
Schwab U.s. Reit Etf Etf (SCHH)
Spdr Nuveen Bloomberg Barclays Municipal Bond Etf Etf (TFI)
Ishares Msci Emerging Markets Etf Etf (EEM)
Spdr Nuveen Bloomberg Barclays Short Term Municipal Bond Etf Etf (SHM)
Schwab Emerging Markets Equity Etf Etf (SCHE)

View all positions for Reby Advisors

Top funds holding GlaxoSmithKline

Kahn Brothers Group
Damian Sousa
Columbia Asset Management
Paradigm Asset Management Company
Park Circle
Byrne Asset Management
Huntington National Bank

View all funds holding GlaxoSmithKline